Method for enhancing the antibody response to specific antigens with Interleukin-10
US5866134A · kind A · utility
23Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 1995 |
| Grant date | Feb 2, 1999 |
| Priority date | — |
| Expiry date | Mar 24, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55527
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for enhancing the immune response of a mammal to a vaccine comprising administering to such a mammal an effective amount of IL-10 in conjunction with the vaccine. A pharmaceutical composition comprised of an effective amount of IL-10, a natural, synthetic or recombinant antigen and a pharmaceutcally acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.